Targets for bacterial resistance: recent advances in small-molecule FtsZ inhibitors
Future Medicinal Chemistry · 2026
DOI: 10.1080/17568919.2026.2642580 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Future Medicinal Chemistry, 2026. Verfasst von Wu-Bin Shao und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, P. R. China. Hauptthemen laut MEDLINE: Bacterial Proteins, Cytoskeletal Proteins, Anti-Bacterial Agents, Small Molecule Libraries. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Guizhou Key Laboratory of Modern Traditional Chinese Medicine Creation, High-level Innovative Talents of Guizhou Province, National Administration of Traditional Chinese Medicine High-level Key Disciplines Development Project.
Abstract (Originalsprache)
ESKAPE pathogens (including Staphylococcus aureus, Enterococcus faecalis, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacteriaceae) represent a core challenge in the global antimicrobial resistance (AMR) crisis. Their multidrug resistance and high transmissibility pose severe clinical threats. However, the pharmaceutical industry's current motivation for developing new drugs targeting these resistant bacteria remains insufficient. Consequently, creating antibiotics with novel mechanisms of action has become a strategic imperative for safeguarding global public health security. Therefore, targeting the bacterial cell division core protein filamentous heat-sensitive Z (FtsZ) has emerged as a key strategy to address the AMR crisis. FtsZ exhibits high conservation and prokaryotic specificity, making it an ideal target for developing novel antimicrobial agents. This paper systematically reviews the structural and functional mechanisms of FtsZ and summarizes research progress on inhibitors targeting its GTPase activity or assembly process - including natural products, synthetic small molecules, peptides, and nanomaterials - based on their sources and structural types. Consequently, drug development targeting FtsZ holds promise as a breakthrough solution for treating infections caused by drug-resistant bacteria such as ESKAPE pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, P. R. China.
- State Key Laboratory of Green Pesticides, State Key Laboratory Breeding Base of Green Pesticide and Agricultural Bioengineering, Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education,…
- Guizhou Key Laboratory of Modern Traditional Chinese Medicine Creation, Guiyang, P. R. China.
ORCID-Profile: Wu-Bin Shao, Xiang Zhou, Song Yang
Förderung
- Guizhou Key Laboratory of Modern Traditional Chinese Medicine Creation
- High-level Innovative Talents of Guizhou Province
- National Administration of Traditional Chinese Medicine High-level Key Disciplines Development Project
Zitieren
APA
Shao, W. B., Zhou, X., Yang, S., & Zhou, Y. (2026). Targets for bacterial resistance: recent advances in small-molecule FtsZ inhibitors. Future Medicinal Chemistry. https://doi.org/10.1080/17568919.2026.2642580
Vancouver
Shao WB, Zhou X, Yang S, Zhou Y. Targets for bacterial resistance: recent advances in small-molecule FtsZ inhibitors. Future Medicinal Chemistry. 2026. doi:10.1080/17568919.2026.2642580
BibTeX
@article{Shao2026,
author = {Shao, Wu-Bin and Zhou, Xiang and Yang, Song and Zhou, Ying},
title = {Targets for bacterial resistance: recent advances in small-molecule FtsZ inhibitors},
journal = {Future Medicinal Chemistry},
year = {2026},
doi = {10.1080/17568919.2026.2642580}
}
EUVIMED